SCHEMBL7300749

SCHEMBL7300749

CC1(C)O[C@H]([C@H](O)Cc2ccccc2)[C@@H]([C@H](O)Cc2ccccc2)O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.41
CYP3A4 P08684 1/20 0.41
MAPK1 P28482 1/20 0.41
ANPEP P15144 1/20 0.40
LAP3 P28838 1/20 0.40
TAAR1 Q96RJ0 4/20 0.38
SLC6A2 P23975 2/20 0.38
SIGMAR1 Q99720 2/20 0.38
MAOA P21397 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
CYP2A6 P11509 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
CYP1A2 P05177 1/20 0.37
ALDH1A1 P00352 1/20 0.36
EPHX1 P07099 1/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9708802 1.00 TRPA1 (0.41) TRPA1CYP3A4MAPK1ANPEPLAP3
SCHEMBL7277789 1.00 TRPA1 (0.41) TRPA1CYP3A4MAPK1ANPEPLAP3
SCHEMBL9708851 1.00 TRPA1 (0.41) TRPA1CYP3A4MAPK1ANPEPLAP3
SCHEMBL7976426 0.83 TRPA1 (0.42) TRPA1CYP3A4MAPK1ANPEPLAP3
SCHEMBL7305610 0.81 HTR2A (0.47) SLC6A2SIGMAR1SLC6A4SLC6A3CYP2A6
SCHEMBL5470537 0.81 ALDH1A1 (0.58) CYP3A4CYP1A2ALDH1A1MEN1POLB
SCHEMBL5477128 0.81 ALDH1A1 (0.58) CYP3A4CYP1A2ALDH1A1MEN1POLB
SCHEMBL9699771 0.80 SIGMAR1 (0.37) TRPA1CYP3A4MAPK1SIGMAR1SLC6A3
SCHEMBL7451566 0.79 HTT (0.58) MAPK1POLBKMT2A
SCHEMBL8945893 0.79 LAP3 (0.47) CYP3A4MAPK1ANPEPLAP3TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5712417-A Inhibitors of retroviral proteases ABBOTT LABORATORIES (US) 1998-01-27 US disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0652009-A1 Identification and use of protease inhibitors ELI LILLY AND COMPANY (US) 1995-05-10 EP disclosed
EP-0538396-A4 1994-04-13 EP disclosed
EP-0575097-A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS ELI LILLY AND COMPANY (US) 1993-12-22 EP disclosed
EP-0538396-A1 INHIBITORS OF RETROVIRAL PROTEASES SMITHKLINE BEECHAM CORPORATION (US) 1993-04-28 EP disclosed
WO-1992000948-A1 INHIBITORS OF RETROVIRAL PROTEASES SMITHKLINE BEECHAM CORPORATION (US) 1992-01-23 WO disclosed
EP-0428849-A2 Retroviral protease inhibitors HOECHST AKTIENGESELLSCHAFT (DE) 1991-05-29 EP disclosed